Bank Of New York Mellon Corp Amphastar Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$27.99 - $37.92 $9.72 Million - $13.2 Million	347,212 New	347,212 $13 Billion
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $9.66 Million - $10.8 Million	346,016 New	346,016 $9.7 Million
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $81,880 - $112,155	-2,971 Reduced 0.81%	362,875 $10.2 Million
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $1.06 Million - $1.5 Million	-35,559 Reduced 8.86%	365,846 $12.7 Million
Q1 2022 May 11, 2022	BUY	$22.96 - $36.45 $699,407 - $1.11 Million	30,462 Added 8.21%	401,405 $14.4 Million
Q4 2021 Feb 11, 2022	BUY	$18.14 - $23.29 $125,946 - $161,702	6,943 Added 1.91%	370,943 $8.64 Million
Q3 2021 Nov 12, 2021	BUY	$17.83 - $21.49 $150,699 - $181,633	8,452 Added 2.38%	364,000 $6.92 Million
Q2 2021 Aug 11, 2021	SELL	$17.11 - $20.92 $395,839 - $483,984	-23,135 Reduced 6.11%	355,548 $7.17 Million
Q1 2021 May 13, 2021	SELL	$17.21 - $20.65 $131,983 - $158,364	-7,669 Reduced 1.98%	378,683 $6.94 Million
Q4 2020 Feb 09, 2021	BUY	$17.76 - $21.24 $5,807 - $6,945	327 Added 0.08%	386,352 $7.77 Million
Q3 2020 Nov 12, 2020	BUY	$17.99 - $22.22 $151,493 - $187,114	8,421 Added 2.23%	386,025 $7.24 Million
Q2 2020 Aug 12, 2020	BUY	$14.25 - $22.46 $65,892 - $103,855	4,624 Added 1.24%	377,604 $8.48 Million
Q1 2020 May 06, 2020	SELL	$12.66 - $20.08 $199,838 - $316,962	-15,785 Reduced 4.06%	372,980 $5.54 Million
Q4 2019 Feb 14, 2020	BUY	$17.07 - $20.64 $92,929 - $112,364	5,444 Added 1.42%	388,765 $7.5 Million
Q3 2019 Nov 07, 2019	SELL	$19.12 - $22.62 $125,752 - $148,771	-6,577 Reduced 1.69%	383,321 $7.6 Million
Q2 2019 Aug 12, 2019	SELL	$18.92 - $22.96 $198,319 - $240,666	-10,482 Reduced 2.62%	389,898 $8.23 Million
Q1 2019 May 14, 2019	SELL	$19.46 - $25.28 $909,716 - $1.18 Million	-46,748 Reduced 10.46%	400,380 $8.18 Million
Q4 2018 Feb 11, 2019	BUY	$17.72 - $22.51 $500,146 - $635,344	28,225 Added 6.74%	447,128 $8.9 Million
Q3 2018 Nov 09, 2018	BUY	$15.39 - $19.38 $166,781 - $210,021	10,837 Added 2.66%	418,903 $0
Q2 2018 Aug 06, 2018	SELL	$14.63 - $19.6 $92,490 - $123,911	-6,322 Reduced 1.53%	408,066 $6.23 Million
Q1 2018 May 15, 2018	BUY	$17.23 - $20.35 $165,390 - $195,339	9,599 Added 2.37%	414,388 $7.77 Million
Q4 2017 Feb 09, 2018	BUY	$17.76 - $19.75 $7.19 Million - $7.99 Million	404,789	404,789 $7.79 Million

Others Institutions Holding AMPH

# of Institutions

280

Shares Held

36.7M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account